Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FST
1176
DELISTED
FOREST OIL CORPORATION
FST
| $5.39M | 0.01% |
2,365,895
-2,437,102
| -51% | -$5.19M |
|
1177
OGE Energy
OGE
$9.69B
| $5.39M | 0.01% |
138,000
-172,388
| -56% | -$6.31M |
|
1178
STRATTEC Security
STRT
$338M
| $5.38M | 0.01% |
83,365
+13,353
| +19% | +$901K |
|
|
WCG
1179
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.37M | 0.01% |
71,900
+36,580
| +104% | +$2.61M |
|
|
ETFC
1180
DELISTED
E*Trade Financial Corporation
ETFC
| $5.36M | 0.01% |
251,940
-1,053,138
| -81% | -$22.1M |
|
|
HTB
1181
HomeTrust Bancshares
HTB
$831M
| $5.35M | 0.01% |
339,003
+236,024
| +229% | +$3.65M |
|
1182
Hyster-Yale Materials Handling
HY
$614M
| $5.33M | 0.01% |
60,200
+26,274
| +77% | +$2.38M |
|
|
BELFB
1183
Bel Fuse Inc Class B
BELFB
$4.25B
| $5.31M | 0.01% |
207,017
-26,000
| -11% | -$617K |
|
1184
Nasdaq
NDAQ
$54.6B
| $5.31M | 0.01% |
412,500
-2,709
| -0.7% | -$33.1K |
|
|
ELOS
1185
DELISTED
Syneron Medical Ltd
ELOS
| $5.3M | 0.01% |
513,680
-72,700
| -12% | -$786K |
|
1186
Range Resources
RRC
$9.39B
| $5.3M | 0.01% |
+60,950
| New | +$5.45M |
|
1187
RadNet
RDNT
$6.08B
| $5.3M | 0.01% |
+798,900
| New | +$4.59M |
|
1188
Eagle Bancorp
EGBN
$877M
| $5.29M | 0.01% |
156,806
+58,126
| +59% | +$1.95M |
|
1189
Silicom
SILC
$268M
| $5.29M | 0.01% |
126,000
-45,203
| -26% | -$2.22M |
|
1190
Unitil
UTL
$992M
| $5.26M | 0.01% |
155,600
+19,600
| +14% | +$650K |
|
|
EXFO
1191
DELISTED
EXFO INC.
EXFO
| $5.26M | 0.01% |
1,096,000
+4,270
| +0.4% | +$19.7K |
|
1192
Littelfuse
LFUS
$11.4B
| $5.26M | 0.01% |
56,592
-48,500
| -46% | -$4.44M |
|
1193
FormFactor
FORM
$10.3B
| $5.26M | 0.01% |
631,700
-107,717
| -15% | -$715K |
|
1194
LivePerson
LPSN
$35.9M
| $5.24M | 0.01% |
34,400
+20,692
| +151% | +$3.09M |
|
|
NTK
1195
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $5.21M | 0.01% |
58,100
-5,004
| -8% | -$423K |
|
1196
ICF International
ICFI
$1.6B
| $5.19M | 0.01% |
146,700
+28,297
| +24% | +$1.06M |
|
|
FFIC
1197
DELISTED
Flushing Financial
FFIC
| $5.16M | 0.01% |
251,288
+34,188
| +16% | +$687K |
|
|
DFZ
1198
DELISTED
BARRY (R.G.) CORPORATION
DFZ
| $5.16M | 0.01% |
272,400
-76,877
| -22% | -$1.45M |
|
1199
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $5.12M | 0.01% |
+156,600
| New | +$4.79M |
|
|
BLOX
1200
DELISTED
Infoblox Inc
BLOX
| $5.12M | 0.01% |
389,200
-172,079
| -31% | -$2.95M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.